Announcements Trials
Browse Landscape

Phase

Phase NA 35Phase 3 4Phase 2 2Phase 4 1

Status

Completed 2

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 3Other hematologic neoplasm 2Lymphoid 2Breast 2Sarcoma 1Head & Neck 1Endocrine 1

Conditions

Breast Neoplasms 2Pain, Postoperative 1Agnosia 1

Interventions

Trastuzumab 349Paclitaxel 310Cyclophosphamide 286Docetaxel 267Carboplatin 215Capecitabine 215Letrozole 185Fulvestrant 178Doxorubicin 166Bevacizumab 136Anastrozole 120Tamoxifen 117pertuzumab 114pembrolizumab 113Epirubicin 110exemestane 107Vinorelbine 106Gemcitabine 106Albumin-Bound Paclitaxel 92Lapatinib 84130-nm albumin-bound paclitaxel 83Radiotherapy 79palbociclib 75eribulin 73Cisplatin 69pyrotinib 66Taxes 65Everolimus 55Goserelin 50Drug Therapy 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Control Groups × Breast × Clear all
NCT07081581 2025-07-23

Analgesic Effect of Serratus Plane Block With Adjuvant Agents in Breast Cancer Surgery

Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey

Phase 2 Completed
75 enrolled
Breast

Agnosia, Breast Neoplasms, Pain, Postoperative

NCT04222790 2023-12-04

A Study of Monosialic Gangliosides to Prevent Albumin-bound Paclitaxel Neurotoxicity

Henan Cancer Hospital

Phase 2 Completed
159 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡